Found 7 matching trials
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
PHASE2The purpose of this study is to evaluate the efficacy (disease response) an...
Location
Birmingham Hematology and Oncology Associates, LLC
Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
PHASE2The purpose of this study is to evaluate the safety, efficacy and exposure ...
Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
PHASE2The purpose of this study is to evaluate the efficacy and safety of TRM-1 i...
Location
University of Colorado Cancer Center
Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
PHASE1Chemoradiotherapy has become the standard of care for women with locally ad...
Location
University Medical Center Groningen
Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
PHASE1Mapatumumab is a fully human, agonist monoclonal antibody that activates th...
Location
GSK Investigational Site
Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
PHASE2The purpose of this study is to evaluate the efficacy (disease response) an...
Location
Mayo Clinic Arizona
A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
PHASE1The purpose of this study is to evaluate the safety and tolerability of esc...
Location
Cedars-Sinai Health System